-
Massive Acquisition Of Obesity Drug Developer, Clinical Programs For Rare Genetic Disease, Clinical Translation Of Gene Therapies, More
Clinical Research News | Novo Nordisk acquires Inversago Pharma and the development of an appetite regulator; ADARx Pharmaceuticals will advance clinical programs on a rare genetic disease with new funding; Kriya Therapeutics plans to use Series C funding for clinical translation of gene therapies; more.
Aug 30, 2023
-
AI-Powered inClinico Aims To Solve The Phase 2-To-3 Transition Problem
Clinical Research News | Insilico Medicine recently broke the news that one of its platforms, powered by artificial intelligence (AI), succeeded in predicting the outcomes of several phase 2 clinical trials.
Aug 24, 2023
-
Novel Biomarker Tracks Tightly With Tau Tangles In Alzheimer’s Disease
Clinical Research News | Researchers in the U.S. and Sweden have identified a biomarker (MTBR-tau243) for Alzheimer’s disease that tracks with the amount of damaging tau tangles in the brain and, when combined with a specific phosphorylated tau species (p-tau205), is nearly as predictive of cognitive function as tau-positron emission tomography (tau-PET) imaging.
Aug 23, 2023
-
‘Swarm Learning’ Approach To Improving Care Of Colorectal Cancer Patients
Clinical Research News | Over the next three years, researchers from across five universities in Germany will be using “swarm learning” on retrospective tissue samples to gain insights on the tumor biology of hereditary colorectal cancer (CRC).
Aug 22, 2023
-
Toward Optimizing Site Feasibility Assessment For Clinical Trials
Clinical Research News | Selecting appropriate sites is one of the most crucial factors for determining successful completion of a clinical trial. It is important to ensure that potential trial sites have the capability to meet the protocol requirements and the capacity to deliver the study objectives in a safe and efficient manner.
Aug 18, 2023
